XML 34 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:    
Research and development $ 38,790,603 $ 16,515,543
General and administrative 6,244,408 8,995,736
Total operating expenses 45,035,011 25,511,279
Operating loss (45,035,011) (25,511,279)
Other income (expense):    
Interest income 667,898 182,712
Change in fair value of warrants (11,837,200)
Total other (expense) income (11,169,302) 182,712
Net loss before income taxes (56,204,313) (25,328,567)
Income tax expense (benefit)
Net loss $ (56,204,313) $ (25,328,567)
Basic loss per common share $ (6.23) $ (3.10)
Diluted loss per common share $ (6.23) $ (3.10)
Weighted average number of common shares outstanding, basic 9,023,138 8,162,326
Weighted average number of common shares outstanding, diluted 9,023,138 8,162,326